Ls9

Twist Bioscience Corporation, based in South San Francisco, is a leading synthetic biology company specializing in innovative silicon-based DNA synthesis. The company offers a range of high-quality synthetic DNA tools, including gene synthesis, oligo pools, exome, NGS target enrichment, and variant libraries, catering to diverse research and biotechnology needs. Generated from their website's infomation

First Databank, located in South San Francisco, CA, specializes in providing comprehensive applications tailored for various sectors in healthcare, including ambulatory health, hospital care, and long-term care. Their innovative solutions empower clinicians and consumers alike with tools for medication management, electronic health records, and streamlined order entry, ultimately enhancing patient care and operational efficiency. By leveraging advanced data analytics, First Databank supports improved medication adherence, drug pricing analysis, and drug formulary management, fostering informed decision-making across the healthcare continuum. Their focus on enhancing the electronic flow of medication information and patient engagement aims to optimize health outcomes and facilitate reliable transitions of care. Generated from the website

Allogene Therapeutics, Inc., based in South San Francisco, CA, is a pioneering biotechnology company focused on developing innovative allogeneic CAR T-cell therapies for the treatment of blood cancers, solid tumors, and autoimmune diseases. Their proprietary AlloCART product platform leverages advanced multiplex gene engineering and state-of-the-art manufacturing techniques to optimize treatment efficacy and accessibility. The company is currently enrolling participants in the ALPHA3 trial, the industry's first pivotal Phase 2 first-line consolidation trial for an investigational allogeneic CAR T therapy in large B-cell lymphoma. With a highly experienced management team, Allogene is dedicated to leading the next revolution in cell therapy, aiming to deliver scalable and efficient treatment options to patients. Generated from the website